News
Vinay Prasad’s ouster as the Food and Drug Administration’s top vaccine and gene therapy regulator came after frustration ...
One of the most notable accomplishments of the first Trump Administration was its willingness to take on the status quo of ...
Vinay Prasad, a professor who until earlier this year headed a cancer-drugs and health-policy lab at UC San Francisco, ...
George Tidmarsh takes over temporarily at CBER following Vinay Prasad’s abrupt departure; Replimmune trial leaders protest ...
23hOpinion
The New Republic on MSNTrump Manages to Be Racist While Admitting He’s Wrecking FarmsTrump appeared to acknowledge in the interview that his ruthless mass deportation campaign is hurting farms, which rely on ...
Dr. Vinay Prasad had been serving as the FDA's director of the Center for Biologics Evaluation and Research since May, and ...
The president overruled his HHS secretary and FDA chief, four people with knowledge of the decision tell POLITICO.
18hOpinion
The New Republic on MSNIs Trump About to Drag Joe Rogan Into the Epstein Files Debacle?The Trump administration has been in a tailspin over the case files since the beginning of July, when the Justice Department ...
Sarepta Therapeutics (SRPT) stock in focus as report says company hired a Trump-linked lobbying firm after deaths linked to ...
In this week’s edition of InnovationRx, we look at a biotech entrepreneur treating a rare genetic disease, new tech aimed at ...
18h
Money Talks News on MSNPopular Food Coloring Gets FDA Boot Over Cancer ConcernsOzzy Osbourne’s cause of death revealed after rock legend’s funeral My Wife Of 45 Years Died. I Thought I Truly Knew Her — ...
19h
Money Talks News on MSNFDA Study Links Low-Dose CBD to Liver Damage in Some Healthy AdultsFDA clinical trial reveals CBD may cause liver enzyme elevation in 5% of users, with women showing higher vulnerability than men.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results